Clinical trial
A Phase-IIa, Double-blind, Randomized, Placebo-controlled Study on the Safety and Early Efficacy of Alkaline Phosphatase in Sepsis Patients With Renal Failure
NCT00511186 is registered in ClinicalTrials.gov with AM-Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase-IIa, Double-blind, Randomized, Placebo-controlled Study on the Safety and Early Efficacy of Alkaline Phosphatase in Sepsis Patients With Renal Failure
- Lead sponsor
- AM-Pharma
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- May 31, 2008
- Completion date
- December 31, 2009
- Enrollment
- 36 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.